Heart Rhythm Society Calls On Industry, FDA To Overhaul Device Surveillance
This article was originally published in The Gray Sheet
Executive Summary
Draft recommendations from the Heart Rhythm Society would increase the clarity and amount of information industry gives FDA, physicians and patients on pacemaker and implantable cardioverter defibrillator (ICD) performance
You may also be interested in...
Medtronic Fidelis Fracture Rates Accelerate Over Time, Study Finds
Fracture rates with Medtronic's Sprint Fidelis implantable cardioverter defibrillator leads are increasing over time, according to new research published online Feb. 23 by the journal HeartRhythm
Medtronic Fidelis Fracture Rates Accelerate Over Time, Study Finds
Fracture rates with Medtronic's Sprint Fidelis implantable cardioverter defibrillator leads are increasing over time, according to new research published online Feb. 23 by the journal HeartRhythm
Heart Rhythm Society Finalizes Recommendations, Urges Postmarket Reform
The Heart Rhythm Society's final recommendations for industry, FDA and physicians on handling malfunctions of implantable heart devices, issued Sept. 28, "are only the beginning of what needs to happen," said HRS President Dwight Reynolds, MD